Optimizing conditions for gene transfer into human hematopoietic cells

Progress in Experimental Tumor Research

Volumn 36, Issue , 1999, Pages 20-49

  Moore, Malcolm A S ^a   MacKenzie, Karen L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; METHODOLOGY; REVIEW;

GENE THERAPY; GENE TRANSFER TECHNIQUES; HEMATOPOIETIC STEM CELLS; HUMANS; TRANSDUCTION, GENETIC;

EID: 0032619449     PISSN: 00796263     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061987     Document Type: Article

References (138)

1. Bodine DM, Moritz T, Donahue RE, Luskey BD, Kessler SW, Margin DI, Orkin SH, Nienhuis AW, Williams DA: Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells. Blood 1993;82:1975-1980.
2. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavilio F: Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 1995;270:470-475.
3. Kohn DB, Weinberg KJ, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Grooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Nbastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfied MS, Mullen CA, Blaese RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1995;1:1017-1023.
4. Raftopoulos H, Ward M, Bank A: High-level transfer and long-term expression of the human betaglobin gene in a mouse transplant model. Ann NY Acad Sci 1998;850:178-190.
5. Takekoshi KJ, Oh YH, Westerman KW, London IM, Leboulch P: Retroviral transfer of a human beta-globin/delta-globin hybrid gene linked to beta locus control region hypersensitive site 2 aimed at the gene therapy of sickle cell disease. Proc Natl Acad Sci USA 1995;92:3014-3018.
6. Sadelain M, Wang CH, Antoniou M, Grosveld F, Mulligan RC: Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene. Proc Natl Acad Sci USA 1995;92:6728-6732.
7. Pawliuk R, Bachelot T, Raftopoulos H, Kalberer C, Humphries RK, Bank A, Leboulch P: Retroviral vectors aimed at the gene therapy of human beta-globin gene disorders. Ann NY Acad Sci 1998; 850:151-162.
8. Xu L-C, Kluepfel-Stahl S, Blanco M, Schiffmann R, Dunbar C, Karlsson S: Growth factors and stromal support generate very efficient retroviral transduction of peripheral blood CD34+ cells from Gaucher patients. Blood 1995;86:141-146.
9. Migita M, Medin JA, Pawliuk R, Jacobson S, Nagle JW, Anderson S, Amiri M, Humphries RK, Karlsson S: Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors. Proc Natl Acad Sci USA 1995;92:12075-12079.
10. Donahue RE, Byrne ER, Kirby MR, Agricola BA, Sellers ES, Gaudernack G, Karlsson S, Lansdorp PM: Transplantation and gene transfer of the human glucocerebrosidase gene into immunoselected primate CD34+/Thy-1+ cells. Blood 1996;88:4166-4172.
11. Bauer TR, Schwartz BR, Liles C, Ochs HD, Hickstein DD: Retroviral-mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD34+ cells derived froma patient with leukocyte adhesion deficiency type I. Blood 1998;91:1520-1526.
12. Porter CD, Parkar MH, Collins MKL, Levinsky RJ, Kinnon C: Efficient retroviral transduction of human bone marrow progenitor and long-term culture-initiating cells: Partial reconstitution of cells from patients with X-linked chronic granulomatous disease by gp91-phox expression. Blood 1996;87:3722-3730.
13. Gilboa E, Smith C: Gene therapy for infectious disease: The AIDS model. Trends Genet 1994;10: 139-144.
14. Mark CL, Yu M, Yamada O, Kraus G, Looney D, Poeschla E, Wong-Staal F: Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes. Hum Gene Ther 1994;5:1115.
15. Sun LQ, Pyati J, Smythe J, Wang L, Macpherson J, Gerlach W, Symonds G: Resistance of human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric transactivation response element constructs. Proc Natl Acad Sci USA 1995;92:7272-7276.
16. Wang L, Witherington C, King A, Gerlach WL, Carr A, Penny R, Cooper D, Symonds G, Sun LQ: Preclinical characterization of an anti-tat ribozyme for therapeutic application. Hum Gene Ther 1998;9:1283-1291.
17. Sun LQ, Ely JA, Gerlach W, Symonds G: Anti-HIV ribozymes. Mol Biotech 1997;7:241-251.
18. Bahner I, Kearns K, Hao QL, Smorgorzewska E, Kohn DB: Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type I replication in myelomonocytic cells produced in long-term culture. J Virol 1996;70:4352-4360.
19. Su L, Lee R, Bonyhadi M, Matsuzake H, Forestell S, Escaich S, Bohnlein E, Kaneshima H: Hematopoietic stem cell-based gene therapy for revM10 in myeloid cells in vivo and in vitro. Blood 1997;89:2283-2290.
20. Bauer G, Balder P, Kearns K, Bahner I, Wen SF, Zaia JA, Kohn DB: Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes. Blood 1997;89:2259.
21. Jelinek J, Fairbairn LJ, Dexter TM, Rafferty JA, Stocking C, Ostertag W, Margison GP: Long-term protection of hematopoiesis against the cytotoxic effects of multiple doses of nitrosourea by retrovirus-mediated expression of human O6-alkylguanine-DNA-alkyltransferase. Blood 1996;87: 1957-1961.
22. Magni M, Shammah S, Schiro R, Mellando W, Dalla-Favera R, Gianni AM: Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood 1996;87:1097-1103.
23. Goldman MJ, Lee PS, Yang JS, Wilson JM: Lentiviral vectors for gene therapy of cystic fibrosis. Hum Gene Ther 1997;8:2261-2268.
24. Blomer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH: Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997;71:6641-6649.
25. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272: 263-267.
26. Naldini L, Blomer U, Gage FH, Trono D, Verma IM: Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996;93:11382-11388.
27. Moore MAS, Hoskins I: Ex vivo expansion of cord blood derived stem cells and progenitors. Blood Cells 1994;20:468-481.
28. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Farrario J, Fagoli F, Berger M, Aglietta M: Extensive amplification and cell-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997;89:2644-2653.
29. Wang JC, Lapidot T, Cashman JD, Doedens M, Addy L, Sutherland DR, Nayar R, Laraya P, Minden M, Keating A, Eaves AC, Eaves CJ, Dick JE: High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood 1998;91:2406-2414.
30. Campain JA, Terrell KL, Tomczak JA, Shpall EJ, Hami LS, Harrison GS: Comparison of retroviralmediated gene transfer into cultured human CD34+ hematopoietic progenitor cells derived from peripheral blood, bone marrow, and fetal umbilical cord blood. Biol Blood Marrow Transplant 1997;3:273-281.
31. Abe T, Ito M, Okamoto Y, Kim HJ, Takaue Y, Yasutomo K, Makimoto A, Yamaue T, Kawano Y, Watanabe T, Shimada T, Kuroda Y: Transduction of retrovirus-mediated NeoR gene into CD34+ cells purified from granulocyte colony-stimulating factor (G-CSF) mobilized infant and cord blood. Exp Hematol 1997;25:966-971.
32. Leonard JP, May C, Gallardo H, Raffi S, Sadelain M, Moore MAS: Retroviral transduction of human hematopoietic progenitor cells using a vector encoding a cell surface marker (LNGFR) to optimize transgene expression and characterize transduced cell populations. Blood 1996;88(suppl 1): 442a.
33. Cheng L, Du C, Lavau C, Chen S, Tong J, Chen BP, Scollay R, Hawley RG, Hill B: Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lymphomyeloid progeny. Blood 1998;92:83-92.
34. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haematopoiesis in cancer patients. Lancet 1993;342:1134-1137.
35. Zanjani M, Amelia-Porada G, Livingstone AG, Flake AW, Ogawa M: Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol 1998;26:353-360.
36. Miller AD: Cell-surface receptors for retroviruses and implications for gene transfer. Proc Natl Acad Sci USA 1996;93:11407-11413.
37. Cone RD, Mulligan RC: High-efficiency gene transfer into mammalian cells: Genetration of helperfree recombinant retrovirus with broad mammalian host range. Proc Natl Acad Sci USA 1984;81: 6349-6363.
38. Danos O, Mulligan RC: Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988;85:6460-6464.
39. Miller AD, Garcia JV, von Suhr N, Lynch CM, Wilson C, Eiden MV: Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 1991;65:2220-2224.
40. Burns JC, Friedmann T, Driever W, Burrascano M, Yee J-K: Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993;89:8033-8037.
41. Orlic D, Girard LJ, Jordan CT, Anderson SM, Cline AP, Bodine DM: The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc Natl Acad Sci USA 1996;93:11097-11102.
42. Kiem H-P, Heyward S, Winkler A, Potter J, Allen JM, Miller AD, Andrews RG: Gene transfer into marrow repopulating cells: Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood 1997;90: 4638-4645.
43. Orlic D, Girard LJ, Anderson SM, Pyle LC, Yoder MC, Broxmeyer HE, Bodine DM: Identification of human and mouse hematopoietic stem cell populations expressing high levels of mRNA encoding retrovirus receptors. Blood 1998;91:3247-3254.
44. Crooks GM, Kohn DB: Growth factors increase amphotropic retrovirus binding to human CD34+ bone marrow progenitor cells. Blood 1993;82:3290-3297.
45. Kiem H-P, Andrews RG, Morris J, Peterson L, Heyward S, Allen JM, Rasko JEJ, Potter J, Miller AD: Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood 1988;92:1878-1886.
46. Marandin A, Dubart A, Pflumbo F, Cosset F-L, Cordette V, Chapel-Fernandes S, Coulombel L, Vainchenker W, Louache F: Retrovirus-mediated gene transfer into human CD34+38 low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo. Hum Gene Ther 1998;9:1497-1511.
47. Takeuchi Y, Cosset F-LC, Lachman PJ, Okada H, Weiss RA, Collins MKL: Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol 1994;68:8001-8007.
48. Cosset F-L, Takeuchi Y, Battini J-L, Weiss RA, Collins MKL: High-titer packaging cells producing recombinant retrovirus resistant to human serum. J Virol 1995;69:7430-7436.
49. Russell DW, Berger MS, Miller AD: The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines. Hum Gene Ther 1995;6:635-641.
50. Akkina RK, Walton RM, Chen ML, Li QX, Planelles V, Chen ISY: High efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J Virol 1996;70:2581-2585.
51. Yam PY, Yee J-K, Ito JI, Sniecinski I, Doroshow JH, Forman SJ, Zaia JA: Comparison of amphotropic and pseudotyped VSV-G retroviral transduction in human CD34+ peripheral blood progenitor cells from adult donors with HIV-1 infection or cancer. Exp Hematol 1998;26:962-968.
52. Case SS, Price MA, Xu D, Bauer G, Naldini L, Verma IM, Kohn DB, Crooks GM: Stable transduction of CD34+/CD38- cells in extended long termculture using a lentiviral vector (abstract 413). Proc Am Soc Gene Ther 1998;104a.
53. Sutton RE, Wu HTM, Rigg R, Bohnlein E, Brown PO: Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J Virol 1998;72:5781-5788.
54. Yee J-K, Miyanohara A, LaPort P, Bouic K, Burns JC, Friedmann T: A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes. Proc Natl Acad Sci USA 1994;91:9564-9568.
55. Yang Y, Vanin EF, Whitt MA, Fornerod M, Zwart R, Schneiderman RD, Grosveld G, Nienhuis AW: Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum Gene Ther 1995;6:1203-1213.
56. Bertran J, Miller JL, Yang Y, Fenimore-Justman A, Rueda F, Vanin EF, Nienhuis AW: Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors. J Virol 1996;70:6759-6766.
57. Scott-Taylor TH, Gallardo HF, Gansbacher B, Sadelain M: Adenovirus facilitated infection of human cells with ecotropic retrovirus. Gene Ther 1998;5:621-629.
58. MacKenzie KL, Hackett NR, Crystal RG, Moore MAS: Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells; transduction and quantification of long-term culture-initiating cells, submitted.
59. Chinswangwatanakul W, Lewis JL, Manning M, Roberts IAG, Gordon MY: Use of G418 resistance to select cells retrovirally transduced with the NeoR gene. Exp Hematol 1998;26:185-186.
60. Movassagh M, Desmyter C, Baillou C, Chapel-Fernandes S, Guigon M, Klatzmann D, Lemoine FM: High-level gene transfer to cord blood progenitors using gibbon ape leukemia virus pseudotype retroviral vectors and an improved clinically applicable protocol. Hum Gene Ther 1998;9: 225-234.
61. Humeau L, Chabannon C, Firpo MT, Mannoni P, Bagnis C, Roncarolo M-G, Namikawa R: Successful reconstruction of human hematopoiesis in the SCID-hu mouse by genetically modified, highly enriched progenitors isolated from fetal liver. Blood 1997;90:3496-3506.
62. Kiem HP, Darovsky B, von Kalle C, Goehle S, Graham T, Miller AD, Storb R, Scuening FG: Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors. Hum Gene Ther 1996;7:89-93.
63. Conneally E, Bardy P, Eaves CJ, Thomas T, Chappel S, Shpall EJ, Humphries RK: Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. Blood 1996;87:456-464.
64. Valtieri M, Schiro R, Chelucci C, Masella B, Testa U, Casella I, Montesoro E, Mariani G, Hassah JH, Peschle C: Efficient transfer of selectable and membrane reporter genes in hematopoietic progenitor and stem cells purified from peripheral blood. Cancer Res 1994;54:4398-4404.
65. Ruggieri L, Aiuti A, Salomoni M, Zappone E, Ferrari G, Bordignon C: Cell-surface marking of CD34+-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer. Hum Gene Ther 1997;8:1611-1623.
66. Hutchings M, Moriwaki K, Dilloo D, Hoffmann T, Kimbrough S, Johnsen HE, Brenner MK, Heslop HE: Increased transduction efficiency of primary hematopoietic cells by physical colocalization of retrovirus and target cells. J Hematother 1998;7:217-224.
67. McCowage GB, Phillips KL, Gentry TL, Hull S, Kurtzberg J, Gilboa E, Smith C: Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells. Exp Hematol 1998;26:288-298.
68. Persons DA, Allay JA, Allay ER, Smeyne RJ, Ashmun RA, Sorrentino BP, Nienhuis AW: Retroviralmediate transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 1997;90:1777-1786.
69. Mazurier F, Moreau-Gaudry F, Maguer-Satta V, Salesse S, Pigeonnier-Lagarde V, Ged C, Belloc F, Lacombe F, Mahon FX, Reiffers J, de Verneuil H: Rapid analysis and efficient selection of human transduced primitive hematopoietic cells using the humanized S65T green fluorescent protein. Gene Ther 1998;5:556-562.
70. Limon A, Briones J, Puig T, Carmona M, Fornas O, Cancelas JA, Nadal M, Garcia J, Rueda F, Barquinero J: High-titer retroviral vectors containing the enhanced green fluorescent protein gene for efficient expression in hematopoietic cells. Blood 1997;90:3316-3321.
71. Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Grignani F, Lanfrancone L, Peschle C, Nolan GP, Pelicci PG: High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the gene fluorescence protein. Cancer Res 1998;58:14-19.
72. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990;10:4239-4242.
73. Lewis PF, Emerman M: Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994;68:510-516.
74. Emmons RVB, Doren S, Zujewski J, Cottler-Fox M, Carter CS, Hines K, O'Shaughnessy JA, Leitman SF, Greenblatt JJ, Cowan K, Dunbar CE: Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo. Blood 1997;89:4040-4046.
75. Flasshove M, Banerjee D, Leonard JP, Mineishi S, Li MX, Bertino JR, Moore MAS: Retroviral transduction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNA. Hum Gene Ther 1998;9:63-71.
76. Flasshove M, Banerjee D, Mineishi S, Li ML, Bertino JR, Moore MAS: Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood 1995;85:566-574.
77. Shapiro F, Yao TJ, Raptis G, Reich L, Norton L, Moore MA: Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer. Blood 1994;84:3567-3574.
78. Shapiro F, Pytowski B, Raffi S, Witte L, Hicklin DJ, Yao TJ, Moore MAS: The effects of Flk-2/ flt3 ligand as compared with c-kit ligand on short-term and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood, bone marrow, and mobilized peripheral blood. J Hematother 1996;5:655-662.
79. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ: Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 1996;93:1470-1474.
80. Petzer AL, Zandstra PW, Piret JM, Eaves CJ: Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: Novel responses to flt-3 ligand and thrombopoietin. J Exp Med 1996;183:2551-2558.
81. Zandstra PW, Conneally E, Petzer AL, Piret JM, Eaves CJ: Cytokine manipulation of primitive human hematopoietic cell self renewal. Proc Natl Acad Sci USA 1997;94:4698-4703.
82. Nolta JA, Smogorzewska EM, Kohn DB: Analysis of optimal conditions for retroviral-mediated transduction of primitive hematopoietic cells. Blood 1995;86:101-110.
83. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson WH, Vowan K, Young NS, Nienhuis AW: Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to longterm engraftment after autologous transplantation. Blood 1995;85:3048-3057.
84. Dao MA, Shah AJ, Crooks GM, Nolta JA: Engraftment and retroviral markings of CD34+ and CD34+CD38- human hematopoietic progenitors assessed in immune-deficient mice. Blood 1998; 91:1243-1255.
85. Dao MA, Hannum CH, Kohn DB, Nolta JA: Flt3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice afer ex vivo retroviralmediated transduction. Blood 1997;89:446-456.
86. Hesforffer C, Ayello J, Ward M, Kaubisch A, Vahdat L, Balmaceda C, Garrett T, Fetell M, Reiss R, Bank A, Antman K: Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol 1998;16:165-172.
87. Veena P, Traycoff CM, Williams DA, McMahel J, Rice S, Cornetta K, Srour EF: Delayed targeting of cytokine-nonresponsive human bone marrow CD34+ cells with retrovirus-mediated gene transfer enhances transduction efficiency and long-term expression of transduced genes. Blood 1998;91: 3693-3701.
88. Boezeman J, Raymakers R, Vierwinden G, Linssen P: Automatic analysis of growth onset, growth rate and colony size of individual bone marrow progenitors. Cytometry 1997;28:305-308.
89. Huang S, Francis K, Law P, Ramakrishna R, Palsson BO, Ho AD: Kinetics and symmetry of initial cell division of human CD34+/CD38- cells from different ontogenic age (abstract 45). Biol Blood Marrow Transplant 1998;4:107.
90. Dao MA, Yu XJ, Nolta JA: Clonal diversity of primitive human hematopoietic progenitors following retroviral marking and long-term engraftment in immune-deficient mice. Exp Hematol 1997;25: 1357-1366.
91. Horwitz M, Malech HL, Anderson SM, Girard LJ, Bodine D, Orlic D: G-CSF mobilized peripheral blood CD34+CD38- hematopoietic stem cells (HSC) are candidate target cells for high efficiency retrovirus gene therapy (abstract 81). Proc Am Soc Gene Ther 1998;21a.
92. Dilber MS, Bjorkstrand B, Li KJ, Smith CIE, Xanthopoulos KG, Gahrton G: Basic fibroblast growth factor increases retroviral-mediated gene transfer into human hematopoietic peripheral blood progenitor cells. Exp Hematol 1994;22:1129-1133.
93. Elwood NJ, Zogos H, Willson T, Begley CG: Retroviral transduction of human progenitor cells: Use of granulocyte colony-stimulating factor plus stem cell factor to mobilize progenitor cells in vivo and stimulation by Flt3/Flk-2 ligand in vitro. Blood 1996;88:4452-4462.
94. Hennemann B, Conneally E, Leboulch P, Rose-John S, Kalberer CP, Humphries RK, Eaves CJ: Efficient gene transfer into human CD34+ cord blood cells and progenitors using a GALV pseudotyped recombinant retrovirus containing the neomycin resistance and the green fluorescent protein (GFP) genes (abstract 342). Proc Am Soc Gene Ther 1998;86a.
95. Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE: Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 1998;92:1131-1141.
96. Mobest D, Junghann I, Fichtner I, Becker M, Just U, Mertelsmann R, Goan S, Henschler R: Kinetics of NOD/SCID mouse repopulating cells (SRC) diverge from colony-forming cells (CFC) and long-termculture-initiating cells (LTC-IC) during ex vivo expansion of CD34+ blood progenitor cells (PBC). Blood 1997;90(suppl 1):365abs.
97. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 1995;333:283-287.
98. Holyoake TL, Alcorn MJ, Richmond L, Farrell E, Pearson C, Green R, Dunlop DJ, Fitzsimons E, Pragnell IB, Franklin IM: CD34+ PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant 1997;19: 1095.
99. Tavassoli M, Konno M, Shiota Y, Omoto E, Minguell JJ, Znajani ED: Enhancement of the grafting efficiency of transplanted marrow cells by preincubation with interleukin-3 and granulocyte-macrophage colony-stimulating factor. Blood 1991;77:1599-1606.
100. Van der Loo JCM, Ploemacher RE: Marrow- and spleen-seeding efficiencies of allmurine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood 1995;85:2598-2606.
101. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996;87:30-37.
102. Yonemura Y, Ku H, Hirayama F, Souza LM, Ogawa M: Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci USA 1996;93:4040.
103. Matsunaga T, Hirayama F, Yonemura Y, Murray R, Ogawa M: Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: Tranduction of negative signals by c and IL-3 proteins of IL-3 receptor and absence of negative regulation by granulocytemacrophage colony-stimulating factor. Blood 1998;92:901.
104. Gan OI, Murdoch B, Larochelle A, Dick JE: Differential maintenance of primitive human SCIDrepopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood 1997;90:641-650.
105. Bhatia M, Bonnet D, Kapp U, Wang JC, Murdoch B, Dick JE: Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997;186:619.
106. Conneally E, Cashman J, Petzer A, Eaves C: Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA 1997;94:9836.
107. Spence SE, Keller JR, Ruscetti FW, McCauslin CS, Gooya JM, Funakoshi S, Longo DL, Murphy WJ: Engraftment of ex vivo expanded and cycling human cord blood hematopoietic progenitor cells in SCID mice. Exp Hematol 1998;26:507-514.
108. Shimizu Y, Ogawa M, Kobayashi M, Almeida-Porada G, Zanjani ED: Engraftment of cultured human hematopoietic cells in sheep. Blood 1998;91:3688.
109. Luens KM, Travis MA, Chen BP, Hill BL, Scollay R, Murray LJ: Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitivehematopoietic progenitors fromhuman CD34+Thy-1+Lin-cells with preserved ability to engraft SCID-hu bone. Blood 1998;91:1206.
110. Jo D-Y, Rafii S, Hamada T, Moore MAS: Transendothelial chemotaxis and marrow homing of hematopoietic stem cells are mediated by stromal cell-derived factor-1 (SDF-1) signaling through the chemokine receptor CXCR4. Blood, submitted.
111. Hatzfeld J, Li ML, Brown EL, Sookdeo H, Levesque JP, O'Toole T, Gurney C, Clark SC, Hatzfeld A: Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides. J Exp Med 1991;174:925-929.
112. Sitnicka E, Ruscetti FW, Priestley GV, Wolf NS, Bartelmez SH: Transforming growth factor β1 directly and reversibly inhibits the initial cell division of long-term repopulating hematopoietic stem cells. Blood 1996;88:82-88.
113. Heinrich MC, Zigler AJ, Chai L: TGF-beta regulated proteins bind to novel c-kit mRNA sequences. Blood 1996;88:541a.
114. Ohishi K, Katayama N, Itoh R, Mahmud N, Miwa H, Kita K, Minami N, Shirakawa S, Lyman SD, Shiku H: Accelerated cell-cycling of hematopoietic progenitors by the flt-3 ligand that is modulated by transforming growth factor-beta. Blood 1996;87:1718-1726.
115. Sansilvestri P, Cardoso AA, Batard P, Panterne B, Hatzfeld A, Lim B, Levesque JP, Monier MN, Hatzfeld J: Early CD 34high cells can be separated into KIThigh cells in which transforming growth factor-beta (TGF-beta) downmodulates c-kit and KITlow cells in which anti-TGF-beta upmodulates c-kit. Blood 1995;86:1729-1735.
116. Schilz AJ, Brouns G, Knob H, Ottmann OG, Hoelzer D, Fauser AA, Thrasher AJ, Grez M: High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. Blood 1998;92:3163-3171.
117. Kearns K, Bahner I, Bauer G, Wei SF, Valdez P, Sheeler S, Woods L, Miller R, Casciato D, Galpin J, Church J, Kohn DB: Suitability of bone marrow from HIV-1 infected donors for retrovirusmediated gene transfer. Hum Gene Ther 1997;8:301-311.
118. Hu R, Oyaizu N, Than S, Kalyanaraman VS, Wang XP, Pahwa S: HIV-1 gp160 induced transforming growth factor-b production in human PBMC. Clin Immunol Immunopathol 1996;80:283-286.
119. Chuck AC, Clarke MF, Palsson BO: Retroviral infection is limited by Brownian motion. Hum Gene Ther 1996;7:1527-1534.
120. Larochelle A, Vormoor J, Hanenberg H, Wang JCY, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato L, Williams DA, Dick JE: Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 1996;2:1329-1331.
121. Dunbar CE, Seidel NE, Doren S, Sellers S, Cline AP, Metzger ME, Agricola BA, Donahue RE, Bodine DM: Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow reproducing cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc. Natl Acad Sci USA 1996;93:11871-11875.
122. Nolta JA, Dao MA, Wells S, Smogorzewska M, Kohn DB: Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc Natl Acad Sci USA 1996;93:2414-2418.
123. Andreadis S, Palsson BO: Kinetics of retrovirus mediated gene transfer: The importance of the intracellular half-life of retroviruses. J Theor Biol 1996;182:1-20.
124. Conneally E, Eaves CJ, Humphries RK: Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood 1998;91:3487-3493.
125. Sekhar M, Kotani H, Doren S, Agarwal R, McGarrity G, Dunbar CE: Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions. Human Gene Ther 1996;7:33-38.
126. Glimm H, Flugge K, Mobest D, Hofmann VM, Postmus J, Henschler R, Lange W, Finke J, Kiem HP, Schulz G, Rosenthal F, Mertelsmann R, von Kalle C: Hum Gene Ther 1998;10:771-778.
127. Kotani H, Newton PB III, Zhang S, Chiang YL, Otto E, Weaver L, Blaese RM, Anderson WF, McGarrity GJ: Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 1994;5:19-28.
128. Bahnson AB, Dunigan JT, Baysal BE, Mohney T, Atchison RW, Nimgaonkar MT, Ball ED, Barranger JA: Centrifugal enhancement of retroviral mediated gene transfer. J Virol Methods 1995; 54:131-143.
129. Emery DW, Wang XC, Andrews RG, Papayannopoulou T: Optimizing monkey models for bone marrow transduction with retrovirus vectors (abstract 344). Proc Am Soc Gene Ther 1998;87a.
130. Chuck AS, Palsson BO: Consistent and high rates of gene transfer can be obtained using flowthrough transduction over a wide range of retroviral titers. Hum Gene Ther 1996;7:743-750.
131. Chuck AS, Palsson BO: Membrane adsorption characteristics determine the kinetics of flow-through transductions. Biotech Bioengineering 1996;51:260-270.
132. Eipers PG, Krauss JC, Palsson BO, Emerson SG, Todd RF III, Clarke MF: Retroviral-mediated gene transfer in human bone marrow cells grown in continuous perfusion culture vessels. Blood 1995;86:3754-3762.
133. Bertolini F, Battaglia M, Corsini C, Lazzari L, Soligo D, Zibera C, Thalmeier K: Engineered stromal layers and continuous flow culture enhance multidrug resistance gene transfer in hematopoietic progenitors. Cancer Res 1996;56:2566-2572.
134. Moritz T, Patel VP, Williams DA: Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 1994;93:1451-1457.
135. Moritz T, Dutt P, Xiao X, Carstanjen D, Vik T, Hanenberg H, Williams DA: Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 1996;88:855-862.
136. Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA: Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996;2:876-882.
137. Hanenberg H, Hashino K, Konishi H, Hock RA, Kato I, Williams DA: Optimization of fibronectinassisted retroviral gene transfer into human CD34+ hematopoietic cells. Hum Gene Ther 1997;8: 2193-2206.
138. Nolta JA, Hanley MB, Kohn DB: Sustained human hematopoiesis in